undamentalytics Newsletter
Sign in

Dyadic International Inc income statement

In fiscal 2025, Dyadic International Inc reported revenue of $3.1m, down 11.6% on the year before, operating income of −$7.2m (a -232.8% margin) and net income of −$7.4m, or −$0.23 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue1122233334
Cost of revenue1111222123
Gross profit0000011211
Research and development2234853222
General and administrative5566766666
Operating income−7−8−9−10−15−10−8−6−7−7
Income tax−0−1000—————
Net income−2−6−8−9−13−10−7−6−7−8
Diluted EPS−$0.07−$0.21−$0.31−$0.34−$0.47——−$0.20−$0.23−$0.21
Diluted shares (average)29m28m27m27m28m28m29m29m33m36m

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DBVT vs DYAIALGS vs DYAICAMP vs DYAIDYAI vs XBIO

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Dyadic International Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Dyadic International Inc.